Global Radiopharmaceutical Market Insight and Forecast to 2026
The research team projects that the Radiopharmaceutical market size will grow from XXX in 2019 to XXX by 2026, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2026.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
Bracco Imaging
GE Healthcare
Nordion
Bayer
IBA Group
Mallinckrodt
Jubilant Pharma
Lantheus
Triad Isotopes
China Isotope & Radiation
Navidea
Eli Lilly
Dongcheng
Advanced Accelerator Applications
SIEMENS
By Type
Actinium-225
Lutetium-177
Radium-223
Holmium-166
Other
By Application
Oncology
Cardiology
Other
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
South Asia
India
Southeast Asia
Indonesia
Thailand
Singapore
Middle East
Turkey
Saudi Arabia
Iran
Africa
Nigeria
South Africa
Oceania
Australia
South America
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Radiopharmaceutical 2015-2020, and development forecast 2021-2026 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2019.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2015-2020 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2021-2026. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Radiopharmaceutical Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).
Market Analysis by Application Type: Based on the Radiopharmaceutical Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Radiopharmaceutical market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
Bracco Imaging
GE Healthcare
Nordion
Bayer
IBA Group
Mallinckrodt
Jubilant Pharma
Lantheus
Triad Isotopes
China Isotope & Radiation
Navidea
Eli Lilly
Dongcheng
Advanced Accelerator Applications
SIEMENS
By Type
Actinium-225
Lutetium-177
Radium-223
Holmium-166
Other
By Application
Oncology
Cardiology
Other
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
South Asia
India
Southeast Asia
Indonesia
Thailand
Singapore
Middle East
Turkey
Saudi Arabia
Iran
Africa
Nigeria
South Africa
Oceania
Australia
South America
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Radiopharmaceutical 2015-2020, and development forecast 2021-2026 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2019.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2015-2020 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2021-2026. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Radiopharmaceutical Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).
Market Analysis by Application Type: Based on the Radiopharmaceutical Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Radiopharmaceutical market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Radiopharmaceutical Revenue
1.4 Market Analysis by Type
1.4.1 Global Radiopharmaceutical Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Actinium-225
1.4.3 Lutetium-177
1.4.4 Radium-223
1.4.5 Holmium-166
1.4.6 Other
1.5 Market by Application
1.5.1 Global Radiopharmaceutical Market Share by Application: 2021-2026
1.5.2 Oncology
1.5.3 Cardiology
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Radiopharmaceutical Market Perspective (2021-2026)
2.2 Radiopharmaceutical Growth Trends by Regions
2.2.1 Radiopharmaceutical Market Size by Regions: 2015 VS 2021 VS 2026
2.2.2 Radiopharmaceutical Historic Market Size by Regions (2015-2020)
2.2.3 Radiopharmaceutical Forecasted Market Size by Regions (2021-2026)
3 MARKET COMPETITION BY MANUFACTURERS
3.1 Global Radiopharmaceutical Production Capacity Market Share by Manufacturers (2015-2020)
3.2 Global Radiopharmaceutical Revenue Market Share by Manufacturers (2015-2020)
3.3 Global Radiopharmaceutical Average Price by Manufacturers (2015-2020)
4 RADIOPHARMACEUTICAL PRODUCTION BY REGIONS
4.1 North America
4.1.1 North America Radiopharmaceutical Market Size (2015-2026)
4.1.2 Radiopharmaceutical Key Players in North America (2015-2020)
4.1.3 North America Radiopharmaceutical Market Size by Type (2015-2020)
4.1.4 North America Radiopharmaceutical Market Size by Application (2015-2020)
4.2 East Asia
4.2.1 East Asia Radiopharmaceutical Market Size (2015-2026)
4.2.2 Radiopharmaceutical Key Players in East Asia (2015-2020)
4.2.3 East Asia Radiopharmaceutical Market Size by Type (2015-2020)
4.2.4 East Asia Radiopharmaceutical Market Size by Application (2015-2020)
4.3 Europe
4.3.1 Europe Radiopharmaceutical Market Size (2015-2026)
4.3.2 Radiopharmaceutical Key Players in Europe (2015-2020)
4.3.3 Europe Radiopharmaceutical Market Size by Type (2015-2020)
4.3.4 Europe Radiopharmaceutical Market Size by Application (2015-2020)
4.4 South Asia
4.4.1 South Asia Radiopharmaceutical Market Size (2015-2026)
4.4.2 Radiopharmaceutical Key Players in South Asia (2015-2020)
4.4.3 South Asia Radiopharmaceutical Market Size by Type (2015-2020)
4.4.4 South Asia Radiopharmaceutical Market Size by Application (2015-2020)
4.5 Southeast Asia
4.5.1 Southeast Asia Radiopharmaceutical Market Size (2015-2026)
4.5.2 Radiopharmaceutical Key Players in Southeast Asia (2015-2020)
4.5.3 Southeast Asia Radiopharmaceutical Market Size by Type (2015-2020)
4.5.4 Southeast Asia Radiopharmaceutical Market Size by Application (2015-2020)
4.6 Middle East
4.6.1 Middle East Radiopharmaceutical Market Size (2015-2026)
4.6.2 Radiopharmaceutical Key Players in Middle East (2015-2020)
4.6.3 Middle East Radiopharmaceutical Market Size by Type (2015-2020)
4.6.4 Middle East Radiopharmaceutical Market Size by Application (2015-2020)
4.7 Africa
4.7.1 Africa Radiopharmaceutical Market Size (2015-2026)
4.7.2 Radiopharmaceutical Key Players in Africa (2015-2020)
4.7.3 Africa Radiopharmaceutical Market Size by Type (2015-2020)
4.7.4 Africa Radiopharmaceutical Market Size by Application (2015-2020)
4.8 Oceania
4.8.1 Oceania Radiopharmaceutical Market Size (2015-2026)
4.8.2 Radiopharmaceutical Key Players in Oceania (2015-2020)
4.8.3 Oceania Radiopharmaceutical Market Size by Type (2015-2020)
4.8.4 Oceania Radiopharmaceutical Market Size by Application (2015-2020)
4.9 South America
4.9.1 South America Radiopharmaceutical Market Size (2015-2026)
4.9.2 Radiopharmaceutical Key Players in South America (2015-2020)
4.9.3 South America Radiopharmaceutical Market Size by Type (2015-2020)
4.9.4 South America Radiopharmaceutical Market Size by Application (2015-2020)
4.10 Rest of the World
4.10.1 Rest of the World Radiopharmaceutical Market Size (2015-2026)
4.10.2 Radiopharmaceutical Key Players in Rest of the World (2015-2020)
4.10.3 Rest of the World Radiopharmaceutical Market Size by Type (2015-2020)
4.10.4 Rest of the World Radiopharmaceutical Market Size by Application (2015-2020)
5 RADIOPHARMACEUTICAL CONSUMPTION BY REGION
5.1 North America
5.1.1 North America Radiopharmaceutical Consumption by Countries
5.1.2 United States
5.1.3 Canada
5.1.4 Mexico
5.2 East Asia
5.2.1 East Asia Radiopharmaceutical Consumption by Countries
5.2.2 China
5.2.3 Japan
5.2.4 South Korea
5.3 Europe
5.3.1 Europe Radiopharmaceutical Consumption by Countries
5.3.2 Germany
5.3.3 United Kingdom
5.3.4 France
5.3.5 Italy
5.3.6 Russia
5.3.7 Spain
5.3.8 Netherlands
5.3.9 Switzerland
5.3.10 Poland
5.4 South Asia
5.4.1 South Asia Radiopharmaceutical Consumption by Countries
5.4.2 India
5.4.3 Pakistan
5.4.4 Bangladesh
5.5 Southeast Asia
5.5.1 Southeast Asia Radiopharmaceutical Consumption by Countries
5.5.2 Indonesia
5.5.3 Thailand
5.5.4 Singapore
5.5.5 Malaysia
5.5.6 Philippines
5.5.7 Vietnam
5.5.8 Myanmar
5.6 Middle East
5.6.1 Middle East Radiopharmaceutical Consumption by Countries
5.6.2 Turkey
5.6.3 Saudi Arabia
5.6.4 Iran
5.6.5 United Arab Emirates
5.6.6 Israel
5.6.7 Iraq
5.6.8 Qatar
5.6.9 Kuwait
5.6.10 Oman
5.7 Africa
5.7.1 Africa Radiopharmaceutical Consumption by Countries
5.7.2 Nigeria
5.7.3 South Africa
5.7.4 Egypt
5.7.5 Algeria
5.7.6 Morocco
5.8 Oceania
5.8.1 Oceania Radiopharmaceutical Consumption by Countries
5.8.2 Australia
5.8.3 New Zealand
5.9 South America
5.9.1 South America Radiopharmaceutical Consumption by Countries
5.9.2 Brazil
5.9.3 Argentina
5.9.4 Columbia
5.9.5 Chile
5.9.6 Venezuela
5.9.7 Peru
5.9.8 Puerto Rico
5.9.9 Ecuador
5.10 Rest of the World
5.10.1 Rest of the World Radiopharmaceutical Consumption by Countries
5.10.2 Kazakhstan
6 RADIOPHARMACEUTICAL SALES MARKET BY TYPE (2015-2026)
6.1 Global Radiopharmaceutical Historic Market Size by Type (2015-2020)
6.2 Global Radiopharmaceutical Forecasted Market Size by Type (2021-2026)
7 RADIOPHARMACEUTICAL CONSUMPTION MARKET BY APPLICATION(2015-2026)
7.1 Global Radiopharmaceutical Historic Market Size by Application (2015-2020)
7.2 Global Radiopharmaceutical Forecasted Market Size by Application (2021-2026)
8 COMPANY PROFILES AND KEY FIGURES IN RADIOPHARMACEUTICAL BUSINESS
8.1 Bracco Imaging
8.1.1 Bracco Imaging Company Profile
8.1.2 Bracco Imaging Radiopharmaceutical Product Specification
8.1.3 Bracco Imaging Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.2 GE Healthcare
8.2.1 GE Healthcare Company Profile
8.2.2 GE Healthcare Radiopharmaceutical Product Specification
8.2.3 GE Healthcare Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.3 Nordion
8.3.1 Nordion Company Profile
8.3.2 Nordion Radiopharmaceutical Product Specification
8.3.3 Nordion Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.4 Bayer
8.4.1 Bayer Company Profile
8.4.2 Bayer Radiopharmaceutical Product Specification
8.4.3 Bayer Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.5 IBA Group
8.5.1 IBA Group Company Profile
8.5.2 IBA Group Radiopharmaceutical Product Specification
8.5.3 IBA Group Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.6 Mallinckrodt
8.6.1 Mallinckrodt Company Profile
8.6.2 Mallinckrodt Radiopharmaceutical Product Specification
8.6.3 Mallinckrodt Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.7 Jubilant Pharma
8.7.1 Jubilant Pharma Company Profile
8.7.2 Jubilant Pharma Radiopharmaceutical Product Specification
8.7.3 Jubilant Pharma Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.8 Lantheus
8.8.1 Lantheus Company Profile
8.8.2 Lantheus Radiopharmaceutical Product Specification
8.8.3 Lantheus Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.9 Triad Isotopes
8.9.1 Triad Isotopes Company Profile
8.9.2 Triad Isotopes Radiopharmaceutical Product Specification
8.9.3 Triad Isotopes Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.10 China Isotope & Radiation
8.10.1 China Isotope & Radiation Company Profile
8.10.2 China Isotope & Radiation Radiopharmaceutical Product Specification
8.10.3 China Isotope & Radiation Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.11 Navidea
8.11.1 Navidea Company Profile
8.11.2 Navidea Radiopharmaceutical Product Specification
8.11.3 Navidea Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.12 Eli Lilly
8.12.1 Eli Lilly Company Profile
8.12.2 Eli Lilly Radiopharmaceutical Product Specification
8.12.3 Eli Lilly Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.13 Dongcheng
8.13.1 Dongcheng Company Profile
8.13.2 Dongcheng Radiopharmaceutical Product Specification
8.13.3 Dongcheng Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.14 Advanced Accelerator Applications
8.14.1 Advanced Accelerator Applications Company Profile
8.14.2 Advanced Accelerator Applications Radiopharmaceutical Product Specification
8.14.3 Advanced Accelerator Applications Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.15 SIEMENS
8.15.1 SIEMENS Company Profile
8.15.2 SIEMENS Radiopharmaceutical Product Specification
8.15.3 SIEMENS Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
9 PRODUCTION AND SUPPLY FORECAST
9.1 Global Forecasted Production of Radiopharmaceutical (2021-2026)
9.2 Global Forecasted Revenue of Radiopharmaceutical (2021-2026)
9.3 Global Forecasted Price of Radiopharmaceutical (2015-2026)
9.4 Global Forecasted Production of Radiopharmaceutical by Region (2021-2026)
9.4.1 North America Radiopharmaceutical Production, Revenue Forecast (2021-2026)
9.4.2 East Asia Radiopharmaceutical Production, Revenue Forecast (2021-2026)
9.4.3 Europe Radiopharmaceutical Production, Revenue Forecast (2021-2026)
9.4.4 South Asia Radiopharmaceutical Production, Revenue Forecast (2021-2026)
9.4.5 Southeast Asia Radiopharmaceutical Production, Revenue Forecast (2021-2026)
9.4.6 Middle East Radiopharmaceutical Production, Revenue Forecast (2021-2026)
9.4.7 Africa Radiopharmaceutical Production, Revenue Forecast (2021-2026)
9.4.8 Oceania Radiopharmaceutical Production, Revenue Forecast (2021-2026)
9.4.9 South America Radiopharmaceutical Production, Revenue Forecast (2021-2026)
9.4.10 Rest of the World Radiopharmaceutical Production, Revenue Forecast (2021-2026)
9.5 Forecast by Type and by Application (2021-2026)
9.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
9.5.2 Global Forecasted Consumption of Radiopharmaceutical by Application (2021-2026)
10 CONSUMPTION AND DEMAND FORECAST
10.1 North America Forecasted Consumption of Radiopharmaceutical by Country
10.2 East Asia Market Forecasted Consumption of Radiopharmaceutical by Country
10.3 Europe Market Forecasted Consumption of Radiopharmaceutical by Countriy
10.4 South Asia Forecasted Consumption of Radiopharmaceutical by Country
10.5 Southeast Asia Forecasted Consumption of Radiopharmaceutical by Country
10.6 Middle East Forecasted Consumption of Radiopharmaceutical by Country
10.7 Africa Forecasted Consumption of Radiopharmaceutical by Country
10.8 Oceania Forecasted Consumption of Radiopharmaceutical by Country
10.9 South America Forecasted Consumption of Radiopharmaceutical by Country
10.10 Rest of the world Forecasted Consumption of Radiopharmaceutical by Country
11 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
11.1 Marketing Channel
11.2 Radiopharmaceutical Distributors List
11.3 Radiopharmaceutical Customers
12 INDUSTRY TRENDS AND GROWTH STRATEGY
12.1 Market Top Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porter’s Five Forces Analysis
12.5 Radiopharmaceutical Market Growth Strategy
13 ANALYST'S VIEWPOINTS/CONCLUSIONS
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Disclaimer
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Radiopharmaceutical Revenue
1.4 Market Analysis by Type
1.4.1 Global Radiopharmaceutical Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Actinium-225
1.4.3 Lutetium-177
1.4.4 Radium-223
1.4.5 Holmium-166
1.4.6 Other
1.5 Market by Application
1.5.1 Global Radiopharmaceutical Market Share by Application: 2021-2026
1.5.2 Oncology
1.5.3 Cardiology
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Radiopharmaceutical Market Perspective (2021-2026)
2.2 Radiopharmaceutical Growth Trends by Regions
2.2.1 Radiopharmaceutical Market Size by Regions: 2015 VS 2021 VS 2026
2.2.2 Radiopharmaceutical Historic Market Size by Regions (2015-2020)
2.2.3 Radiopharmaceutical Forecasted Market Size by Regions (2021-2026)
3 MARKET COMPETITION BY MANUFACTURERS
3.1 Global Radiopharmaceutical Production Capacity Market Share by Manufacturers (2015-2020)
3.2 Global Radiopharmaceutical Revenue Market Share by Manufacturers (2015-2020)
3.3 Global Radiopharmaceutical Average Price by Manufacturers (2015-2020)
4 RADIOPHARMACEUTICAL PRODUCTION BY REGIONS
4.1 North America
4.1.1 North America Radiopharmaceutical Market Size (2015-2026)
4.1.2 Radiopharmaceutical Key Players in North America (2015-2020)
4.1.3 North America Radiopharmaceutical Market Size by Type (2015-2020)
4.1.4 North America Radiopharmaceutical Market Size by Application (2015-2020)
4.2 East Asia
4.2.1 East Asia Radiopharmaceutical Market Size (2015-2026)
4.2.2 Radiopharmaceutical Key Players in East Asia (2015-2020)
4.2.3 East Asia Radiopharmaceutical Market Size by Type (2015-2020)
4.2.4 East Asia Radiopharmaceutical Market Size by Application (2015-2020)
4.3 Europe
4.3.1 Europe Radiopharmaceutical Market Size (2015-2026)
4.3.2 Radiopharmaceutical Key Players in Europe (2015-2020)
4.3.3 Europe Radiopharmaceutical Market Size by Type (2015-2020)
4.3.4 Europe Radiopharmaceutical Market Size by Application (2015-2020)
4.4 South Asia
4.4.1 South Asia Radiopharmaceutical Market Size (2015-2026)
4.4.2 Radiopharmaceutical Key Players in South Asia (2015-2020)
4.4.3 South Asia Radiopharmaceutical Market Size by Type (2015-2020)
4.4.4 South Asia Radiopharmaceutical Market Size by Application (2015-2020)
4.5 Southeast Asia
4.5.1 Southeast Asia Radiopharmaceutical Market Size (2015-2026)
4.5.2 Radiopharmaceutical Key Players in Southeast Asia (2015-2020)
4.5.3 Southeast Asia Radiopharmaceutical Market Size by Type (2015-2020)
4.5.4 Southeast Asia Radiopharmaceutical Market Size by Application (2015-2020)
4.6 Middle East
4.6.1 Middle East Radiopharmaceutical Market Size (2015-2026)
4.6.2 Radiopharmaceutical Key Players in Middle East (2015-2020)
4.6.3 Middle East Radiopharmaceutical Market Size by Type (2015-2020)
4.6.4 Middle East Radiopharmaceutical Market Size by Application (2015-2020)
4.7 Africa
4.7.1 Africa Radiopharmaceutical Market Size (2015-2026)
4.7.2 Radiopharmaceutical Key Players in Africa (2015-2020)
4.7.3 Africa Radiopharmaceutical Market Size by Type (2015-2020)
4.7.4 Africa Radiopharmaceutical Market Size by Application (2015-2020)
4.8 Oceania
4.8.1 Oceania Radiopharmaceutical Market Size (2015-2026)
4.8.2 Radiopharmaceutical Key Players in Oceania (2015-2020)
4.8.3 Oceania Radiopharmaceutical Market Size by Type (2015-2020)
4.8.4 Oceania Radiopharmaceutical Market Size by Application (2015-2020)
4.9 South America
4.9.1 South America Radiopharmaceutical Market Size (2015-2026)
4.9.2 Radiopharmaceutical Key Players in South America (2015-2020)
4.9.3 South America Radiopharmaceutical Market Size by Type (2015-2020)
4.9.4 South America Radiopharmaceutical Market Size by Application (2015-2020)
4.10 Rest of the World
4.10.1 Rest of the World Radiopharmaceutical Market Size (2015-2026)
4.10.2 Radiopharmaceutical Key Players in Rest of the World (2015-2020)
4.10.3 Rest of the World Radiopharmaceutical Market Size by Type (2015-2020)
4.10.4 Rest of the World Radiopharmaceutical Market Size by Application (2015-2020)
5 RADIOPHARMACEUTICAL CONSUMPTION BY REGION
5.1 North America
5.1.1 North America Radiopharmaceutical Consumption by Countries
5.1.2 United States
5.1.3 Canada
5.1.4 Mexico
5.2 East Asia
5.2.1 East Asia Radiopharmaceutical Consumption by Countries
5.2.2 China
5.2.3 Japan
5.2.4 South Korea
5.3 Europe
5.3.1 Europe Radiopharmaceutical Consumption by Countries
5.3.2 Germany
5.3.3 United Kingdom
5.3.4 France
5.3.5 Italy
5.3.6 Russia
5.3.7 Spain
5.3.8 Netherlands
5.3.9 Switzerland
5.3.10 Poland
5.4 South Asia
5.4.1 South Asia Radiopharmaceutical Consumption by Countries
5.4.2 India
5.4.3 Pakistan
5.4.4 Bangladesh
5.5 Southeast Asia
5.5.1 Southeast Asia Radiopharmaceutical Consumption by Countries
5.5.2 Indonesia
5.5.3 Thailand
5.5.4 Singapore
5.5.5 Malaysia
5.5.6 Philippines
5.5.7 Vietnam
5.5.8 Myanmar
5.6 Middle East
5.6.1 Middle East Radiopharmaceutical Consumption by Countries
5.6.2 Turkey
5.6.3 Saudi Arabia
5.6.4 Iran
5.6.5 United Arab Emirates
5.6.6 Israel
5.6.7 Iraq
5.6.8 Qatar
5.6.9 Kuwait
5.6.10 Oman
5.7 Africa
5.7.1 Africa Radiopharmaceutical Consumption by Countries
5.7.2 Nigeria
5.7.3 South Africa
5.7.4 Egypt
5.7.5 Algeria
5.7.6 Morocco
5.8 Oceania
5.8.1 Oceania Radiopharmaceutical Consumption by Countries
5.8.2 Australia
5.8.3 New Zealand
5.9 South America
5.9.1 South America Radiopharmaceutical Consumption by Countries
5.9.2 Brazil
5.9.3 Argentina
5.9.4 Columbia
5.9.5 Chile
5.9.6 Venezuela
5.9.7 Peru
5.9.8 Puerto Rico
5.9.9 Ecuador
5.10 Rest of the World
5.10.1 Rest of the World Radiopharmaceutical Consumption by Countries
5.10.2 Kazakhstan
6 RADIOPHARMACEUTICAL SALES MARKET BY TYPE (2015-2026)
6.1 Global Radiopharmaceutical Historic Market Size by Type (2015-2020)
6.2 Global Radiopharmaceutical Forecasted Market Size by Type (2021-2026)
7 RADIOPHARMACEUTICAL CONSUMPTION MARKET BY APPLICATION(2015-2026)
7.1 Global Radiopharmaceutical Historic Market Size by Application (2015-2020)
7.2 Global Radiopharmaceutical Forecasted Market Size by Application (2021-2026)
8 COMPANY PROFILES AND KEY FIGURES IN RADIOPHARMACEUTICAL BUSINESS
8.1 Bracco Imaging
8.1.1 Bracco Imaging Company Profile
8.1.2 Bracco Imaging Radiopharmaceutical Product Specification
8.1.3 Bracco Imaging Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.2 GE Healthcare
8.2.1 GE Healthcare Company Profile
8.2.2 GE Healthcare Radiopharmaceutical Product Specification
8.2.3 GE Healthcare Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.3 Nordion
8.3.1 Nordion Company Profile
8.3.2 Nordion Radiopharmaceutical Product Specification
8.3.3 Nordion Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.4 Bayer
8.4.1 Bayer Company Profile
8.4.2 Bayer Radiopharmaceutical Product Specification
8.4.3 Bayer Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.5 IBA Group
8.5.1 IBA Group Company Profile
8.5.2 IBA Group Radiopharmaceutical Product Specification
8.5.3 IBA Group Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.6 Mallinckrodt
8.6.1 Mallinckrodt Company Profile
8.6.2 Mallinckrodt Radiopharmaceutical Product Specification
8.6.3 Mallinckrodt Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.7 Jubilant Pharma
8.7.1 Jubilant Pharma Company Profile
8.7.2 Jubilant Pharma Radiopharmaceutical Product Specification
8.7.3 Jubilant Pharma Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.8 Lantheus
8.8.1 Lantheus Company Profile
8.8.2 Lantheus Radiopharmaceutical Product Specification
8.8.3 Lantheus Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.9 Triad Isotopes
8.9.1 Triad Isotopes Company Profile
8.9.2 Triad Isotopes Radiopharmaceutical Product Specification
8.9.3 Triad Isotopes Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.10 China Isotope & Radiation
8.10.1 China Isotope & Radiation Company Profile
8.10.2 China Isotope & Radiation Radiopharmaceutical Product Specification
8.10.3 China Isotope & Radiation Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.11 Navidea
8.11.1 Navidea Company Profile
8.11.2 Navidea Radiopharmaceutical Product Specification
8.11.3 Navidea Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.12 Eli Lilly
8.12.1 Eli Lilly Company Profile
8.12.2 Eli Lilly Radiopharmaceutical Product Specification
8.12.3 Eli Lilly Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.13 Dongcheng
8.13.1 Dongcheng Company Profile
8.13.2 Dongcheng Radiopharmaceutical Product Specification
8.13.3 Dongcheng Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.14 Advanced Accelerator Applications
8.14.1 Advanced Accelerator Applications Company Profile
8.14.2 Advanced Accelerator Applications Radiopharmaceutical Product Specification
8.14.3 Advanced Accelerator Applications Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.15 SIEMENS
8.15.1 SIEMENS Company Profile
8.15.2 SIEMENS Radiopharmaceutical Product Specification
8.15.3 SIEMENS Radiopharmaceutical Production Capacity, Revenue, Price and Gross Margin (2015-2020)
9 PRODUCTION AND SUPPLY FORECAST
9.1 Global Forecasted Production of Radiopharmaceutical (2021-2026)
9.2 Global Forecasted Revenue of Radiopharmaceutical (2021-2026)
9.3 Global Forecasted Price of Radiopharmaceutical (2015-2026)
9.4 Global Forecasted Production of Radiopharmaceutical by Region (2021-2026)
9.4.1 North America Radiopharmaceutical Production, Revenue Forecast (2021-2026)
9.4.2 East Asia Radiopharmaceutical Production, Revenue Forecast (2021-2026)
9.4.3 Europe Radiopharmaceutical Production, Revenue Forecast (2021-2026)
9.4.4 South Asia Radiopharmaceutical Production, Revenue Forecast (2021-2026)
9.4.5 Southeast Asia Radiopharmaceutical Production, Revenue Forecast (2021-2026)
9.4.6 Middle East Radiopharmaceutical Production, Revenue Forecast (2021-2026)
9.4.7 Africa Radiopharmaceutical Production, Revenue Forecast (2021-2026)
9.4.8 Oceania Radiopharmaceutical Production, Revenue Forecast (2021-2026)
9.4.9 South America Radiopharmaceutical Production, Revenue Forecast (2021-2026)
9.4.10 Rest of the World Radiopharmaceutical Production, Revenue Forecast (2021-2026)
9.5 Forecast by Type and by Application (2021-2026)
9.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
9.5.2 Global Forecasted Consumption of Radiopharmaceutical by Application (2021-2026)
10 CONSUMPTION AND DEMAND FORECAST
10.1 North America Forecasted Consumption of Radiopharmaceutical by Country
10.2 East Asia Market Forecasted Consumption of Radiopharmaceutical by Country
10.3 Europe Market Forecasted Consumption of Radiopharmaceutical by Countriy
10.4 South Asia Forecasted Consumption of Radiopharmaceutical by Country
10.5 Southeast Asia Forecasted Consumption of Radiopharmaceutical by Country
10.6 Middle East Forecasted Consumption of Radiopharmaceutical by Country
10.7 Africa Forecasted Consumption of Radiopharmaceutical by Country
10.8 Oceania Forecasted Consumption of Radiopharmaceutical by Country
10.9 South America Forecasted Consumption of Radiopharmaceutical by Country
10.10 Rest of the world Forecasted Consumption of Radiopharmaceutical by Country
11 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
11.1 Marketing Channel
11.2 Radiopharmaceutical Distributors List
11.3 Radiopharmaceutical Customers
12 INDUSTRY TRENDS AND GROWTH STRATEGY
12.1 Market Top Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porter’s Five Forces Analysis
12.5 Radiopharmaceutical Market Growth Strategy
13 ANALYST'S VIEWPOINTS/CONCLUSIONS
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Disclaimer
LIST OF TABLES AND FIGURES
Table 1. Global Radiopharmaceutical Market Share by Type: 2020 VS 2026
Table 2. Actinium-225 Features
Table 3. Lutetium-177 Features
Table 4. Radium-223 Features
Table 5. Holmium-166 Features
Table 6. Other Features
Table 11. Global Radiopharmaceutical Market Share by Application: 2020 VS 2026
Table 12. Oncology Case Studies
Table 13. Cardiology Case Studies
Table 14. Other Case Studies
Table 21. Commodity Prices-Metals Price Indices
Table 22. Commodity Prices- Precious Metal Price Indices
Table 23. Commodity Prices- Agricultural Raw Material Price Indices
Table 24. Commodity Prices- Food and Beverage Price Indices
Table 25. Commodity Prices- Fertilizer Price Indices
Table 26. Commodity Prices- Energy Price Indices
Table 27. G20+: Economic Policy Responses to COVID-19
Table 28. Radiopharmaceutical Report Years Considered
Table 29. Global Radiopharmaceutical Market Size YoY Growth 2021-2026 (US$ Million)
Table 30. Global Radiopharmaceutical Market Share by Regions: 2021 VS 2026
Table 31. North America Radiopharmaceutical Market Size YoY Growth (2015-2026) (US$ Million)
Table 32. East Asia Radiopharmaceutical Market Size YoY Growth (2015-2026) (US$ Million)
Table 33. Europe Radiopharmaceutical Market Size YoY Growth (2015-2026) (US$ Million)
Table 34. South Asia Radiopharmaceutical Market Size YoY Growth (2015-2026) (US$ Million)
Table 35. Southeast Asia Radiopharmaceutical Market Size YoY Growth (2015-2026) (US$ Million)
Table 36. Middle East Radiopharmaceutical Market Size YoY Growth (2015-2026) (US$ Million)
Table 37. Africa Radiopharmaceutical Market Size YoY Growth (2015-2026) (US$ Million)
Table 38. Oceania Radiopharmaceutical Market Size YoY Growth (2015-2026) (US$ Million)
Table 39. South America Radiopharmaceutical Market Size YoY Growth (2015-2026) (US$ Million)
Table 40. Rest of the World Radiopharmaceutical Market Size YoY Growth (2015-2026) (US$ Million)
Table 41. North America Radiopharmaceutical Consumption by Countries (2015-2020)
Table 42. East Asia Radiopharmaceutical Consumption by Countries (2015-2020)
Table 43. Europe Radiopharmaceutical Consumption by Region (2015-2020)
Table 44. South Asia Radiopharmaceutical Consumption by Countries (2015-2020)
Table 45. Southeast Asia Radiopharmaceutical Consumption by Countries (2015-2020)
Table 46. Middle East Radiopharmaceutical Consumption by Countries (2015-2020)
Table 47. Africa Radiopharmaceutical Consumption by Countries (2015-2020)
Table 48. Oceania Radiopharmaceutical Consumption by Countries (2015-2020)
Table 49. South America Radiopharmaceutical Consumption by Countries (2015-2020)
Table 50. Rest of the World Radiopharmaceutical Consumption by Countries (2015-2020)
Table 51. Bracco Imaging Radiopharmaceutical Product Specification
Table 52. GE Healthcare Radiopharmaceutical Product Specification
Table 53. Nordion Radiopharmaceutical Product Specification
Table 54. Bayer Radiopharmaceutical Product Specification
Table 55. IBA Group Radiopharmaceutical Product Specification
Table 56. Mallinckrodt Radiopharmaceutical Product Specification
Table 57. Jubilant Pharma Radiopharmaceutical Product Specification
Table 58. Lantheus Radiopharmaceutical Product Specification
Table 59. Triad Isotopes Radiopharmaceutical Product Specification
Table 60. China Isotope & Radiation Radiopharmaceutical Product Specification
Table 61. Navidea Radiopharmaceutical Product Specification
Table 62. Eli Lilly Radiopharmaceutical Product Specification
Table 63. Dongcheng Radiopharmaceutical Product Specification
Table 64. Advanced Accelerator Applications Radiopharmaceutical Product Specification
Table 65. SIEMENS Radiopharmaceutical Product Specification
Table 101. Global Radiopharmaceutical Production Forecast by Region (2021-2026)
Table 102. Global Radiopharmaceutical Sales Volume Forecast by Type (2021-2026)
Table 103. Global Radiopharmaceutical Sales Volume Market Share Forecast by Type (2021-2026)
Table 104. Global Radiopharmaceutical Sales Revenue Forecast by Type (2021-2026)
Table 105. Global Radiopharmaceutical Sales Revenue Market Share Forecast by Type (2021-2026)
Table 106. Global Radiopharmaceutical Sales Price Forecast by Type (2021-2026)
Table 107. Global Radiopharmaceutical Consumption Volume Forecast by Application (2021-2026)
Table 108. Global Radiopharmaceutical Consumption Value Forecast by Application (2021-2026)
Table 109. North America Radiopharmaceutical Consumption Forecast 2021-2026 by Country
Table 110. East Asia Radiopharmaceutical Consumption Forecast 2021-2026 by Country
Table 111. Europe Radiopharmaceutical Consumption Forecast 2021-2026 by Country
Table 112. South Asia Radiopharmaceutical Consumption Forecast 2021-2026 by Country
Table 113. Southeast Asia Radiopharmaceutical Consumption Forecast 2021-2026 by Country
Table 114. Middle East Radiopharmaceutical Consumption Forecast 2021-2026 by Country
Table 115. Africa Radiopharmaceutical Consumption Forecast 2021-2026 by Country
Table 116. Oceania Radiopharmaceutical Consumption Forecast 2021-2026 by Country
Table 117. South America Radiopharmaceutical Consumption Forecast 2021-2026 by Country
Table 118. Rest of the world Radiopharmaceutical Consumption Forecast 2021-2026 by Country
Table 119. Radiopharmaceutical Distributors List
Table 120. Radiopharmaceutical Customers List
Table 121. Porter's Five Forces Analysis
Table 122. Key Executives Interviewed
Figure 1. North America Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 2. North America Radiopharmaceutical Consumption Market Share by Countries in 2020
Figure 3. United States Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 4. Canada Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 5. Mexico Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 6. East Asia Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 7. East Asia Radiopharmaceutical Consumption Market Share by Countries in 2020
Figure 8. China Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 9. Japan Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 10. South Korea Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 11. Europe Radiopharmaceutical Consumption and Growth Rate
Figure 12. Europe Radiopharmaceutical Consumption Market Share by Region in 2020
Figure 13. Germany Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 14. United Kingdom Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 15. France Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 16. Italy Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 17. Russia Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 18. Spain Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 19. Netherlands Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 20. Switzerland Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 21. Poland Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 22. South Asia Radiopharmaceutical Consumption and Growth Rate
Figure 23. South Asia Radiopharmaceutical Consumption Market Share by Countries in 2020
Figure 24. India Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 25. Pakistan Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 26. Bangladesh Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 27. Southeast Asia Radiopharmaceutical Consumption and Growth Rate
Figure 28. Southeast Asia Radiopharmaceutical Consumption Market Share by Countries in 2020
Figure 29. Indonesia Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 30. Thailand Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 31. Singapore Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 32. Malaysia Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 33. Philippines Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 34. Vietnam Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 35. Myanmar Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 36. Middle East Radiopharmaceutical Consumption and Growth Rate
Figure 37. Middle East Radiopharmaceutical Consumption Market Share by Countries in 2020
Figure 38. Turkey Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 39. Saudi Arabia Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 40. Iran Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 41. United Arab Emirates Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 42. Israel Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 43. Iraq Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 44. Qatar Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 45. Kuwait Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 46. Oman Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 47. Africa Radiopharmaceutical Consumption and Growth Rate
Figure 48. Africa Radiopharmaceutical Consumption Market Share by Countries in 2020
Figure 49. Nigeria Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 50. South Africa Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 51. Egypt Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 52. Algeria Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 53. Morocco Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 54. Oceania Radiopharmaceutical Consumption and Growth Rate
Figure 55. Oceania Radiopharmaceutical Consumption Market Share by Countries in 2020
Figure 56. Australia Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 57. New Zealand Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 58. South America Radiopharmaceutical Consumption and Growth Rate
Figure 59. South America Radiopharmaceutical Consumption Market Share by Countries in 2020
Figure 60. Brazil Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 61. Argentina Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 62. Columbia Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 63. Chile Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 64. Venezuelal Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 65. Peru Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 66. Puerto Rico Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 67. Ecuador Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 68. Rest of the World Radiopharmaceutical Consumption and Growth Rate
Figure 69. Rest of the World Radiopharmaceutical Consumption Market Share by Countries in 2020
Figure 70. Kazakhstan Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 71. Global Radiopharmaceutical Production Capacity Growth Rate Forecast (2021-2026)
Figure 72. Global Radiopharmaceutical Revenue Growth Rate Forecast (2021-2026)
Figure 73. Global Radiopharmaceutical Price and Trend Forecast (2015-2026)
Figure 74. North America Radiopharmaceutical Production Growth Rate Forecast (2021-2026)
Figure 75. North America Radiopharmaceutical Revenue Growth Rate Forecast (2021-2026)
Figure 76. East Asia Radiopharmaceutical Production Growth Rate Forecast (2021-2026)
Figure 77. East Asia Radiopharmaceutical Revenue Growth Rate Forecast (2021-2026)
Figure 78. Europe Radiopharmaceutical Production Growth Rate Forecast (2021-2026)
Figure 79. Europe Radiopharmaceutical Revenue Growth Rate Forecast (2021-2026)
Figure 80. South Asia Radiopharmaceutical Production Growth Rate Forecast (2021-2026)
Figure 81. South Asia Radiopharmaceutical Revenue Growth Rate Forecast (2021-2026)
Figure 82. Southeast Asia Radiopharmaceutical Production Growth Rate Forecast (2021-2026)
Figure 83. Southeast Asia Radiopharmaceutical Revenue Growth Rate Forecast (2021-2026)
Figure 84. Middle East Radiopharmaceutical Production Growth Rate Forecast (2021-2026)
Figure 85. Middle East Radiopharmaceutical Revenue Growth Rate Forecast (2021-2026)
Figure 86. Africa Radiopharmaceutical Production Growth Rate Forecast (2021-2026)
Figure 87. Africa Radiopharmaceutical Revenue Growth Rate Forecast (2021-2026)
Figure 88. Oceania Radiopharmaceutical Production Growth Rate Forecast (2021-2026)
Figure 89. Oceania Radiopharmaceutical Revenue Growth Rate Forecast (2021-2026)
Figure 90. South America Radiopharmaceutical Production Growth Rate Forecast (2021-2026)
Figure 91. South America Radiopharmaceutical Revenue Growth Rate Forecast (2021-2026)
Figure 92. Rest of the World Radiopharmaceutical Production Growth Rate Forecast (2021-2026)
Figure 93. Rest of the World Radiopharmaceutical Revenue Growth Rate Forecast (2021-2026)
Figure 94. North America Radiopharmaceutical Consumption Forecast 2021-2026
Figure 95. East Asia Radiopharmaceutical Consumption Forecast 2021-2026
Figure 96. Europe Radiopharmaceutical Consumption Forecast 2021-2026
Figure 97. South Asia Radiopharmaceutical Consumption Forecast 2021-2026
Figure 98. Southeast Asia Radiopharmaceutical Consumption Forecast 2021-2026
Figure 99. Middle East Radiopharmaceutical Consumption Forecast 2021-2026
Figure 100. Africa Radiopharmaceutical Consumption Forecast 2021-2026
Figure 101. Oceania Radiopharmaceutical Consumption Forecast 2021-2026
Figure 102. South America Radiopharmaceutical Consumption Forecast 2021-2026
Figure 103. Rest of the world Radiopharmaceutical Consumption Forecast 2021-2026
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
Table 1. Global Radiopharmaceutical Market Share by Type: 2020 VS 2026
Table 2. Actinium-225 Features
Table 3. Lutetium-177 Features
Table 4. Radium-223 Features
Table 5. Holmium-166 Features
Table 6. Other Features
Table 11. Global Radiopharmaceutical Market Share by Application: 2020 VS 2026
Table 12. Oncology Case Studies
Table 13. Cardiology Case Studies
Table 14. Other Case Studies
Table 21. Commodity Prices-Metals Price Indices
Table 22. Commodity Prices- Precious Metal Price Indices
Table 23. Commodity Prices- Agricultural Raw Material Price Indices
Table 24. Commodity Prices- Food and Beverage Price Indices
Table 25. Commodity Prices- Fertilizer Price Indices
Table 26. Commodity Prices- Energy Price Indices
Table 27. G20+: Economic Policy Responses to COVID-19
Table 28. Radiopharmaceutical Report Years Considered
Table 29. Global Radiopharmaceutical Market Size YoY Growth 2021-2026 (US$ Million)
Table 30. Global Radiopharmaceutical Market Share by Regions: 2021 VS 2026
Table 31. North America Radiopharmaceutical Market Size YoY Growth (2015-2026) (US$ Million)
Table 32. East Asia Radiopharmaceutical Market Size YoY Growth (2015-2026) (US$ Million)
Table 33. Europe Radiopharmaceutical Market Size YoY Growth (2015-2026) (US$ Million)
Table 34. South Asia Radiopharmaceutical Market Size YoY Growth (2015-2026) (US$ Million)
Table 35. Southeast Asia Radiopharmaceutical Market Size YoY Growth (2015-2026) (US$ Million)
Table 36. Middle East Radiopharmaceutical Market Size YoY Growth (2015-2026) (US$ Million)
Table 37. Africa Radiopharmaceutical Market Size YoY Growth (2015-2026) (US$ Million)
Table 38. Oceania Radiopharmaceutical Market Size YoY Growth (2015-2026) (US$ Million)
Table 39. South America Radiopharmaceutical Market Size YoY Growth (2015-2026) (US$ Million)
Table 40. Rest of the World Radiopharmaceutical Market Size YoY Growth (2015-2026) (US$ Million)
Table 41. North America Radiopharmaceutical Consumption by Countries (2015-2020)
Table 42. East Asia Radiopharmaceutical Consumption by Countries (2015-2020)
Table 43. Europe Radiopharmaceutical Consumption by Region (2015-2020)
Table 44. South Asia Radiopharmaceutical Consumption by Countries (2015-2020)
Table 45. Southeast Asia Radiopharmaceutical Consumption by Countries (2015-2020)
Table 46. Middle East Radiopharmaceutical Consumption by Countries (2015-2020)
Table 47. Africa Radiopharmaceutical Consumption by Countries (2015-2020)
Table 48. Oceania Radiopharmaceutical Consumption by Countries (2015-2020)
Table 49. South America Radiopharmaceutical Consumption by Countries (2015-2020)
Table 50. Rest of the World Radiopharmaceutical Consumption by Countries (2015-2020)
Table 51. Bracco Imaging Radiopharmaceutical Product Specification
Table 52. GE Healthcare Radiopharmaceutical Product Specification
Table 53. Nordion Radiopharmaceutical Product Specification
Table 54. Bayer Radiopharmaceutical Product Specification
Table 55. IBA Group Radiopharmaceutical Product Specification
Table 56. Mallinckrodt Radiopharmaceutical Product Specification
Table 57. Jubilant Pharma Radiopharmaceutical Product Specification
Table 58. Lantheus Radiopharmaceutical Product Specification
Table 59. Triad Isotopes Radiopharmaceutical Product Specification
Table 60. China Isotope & Radiation Radiopharmaceutical Product Specification
Table 61. Navidea Radiopharmaceutical Product Specification
Table 62. Eli Lilly Radiopharmaceutical Product Specification
Table 63. Dongcheng Radiopharmaceutical Product Specification
Table 64. Advanced Accelerator Applications Radiopharmaceutical Product Specification
Table 65. SIEMENS Radiopharmaceutical Product Specification
Table 101. Global Radiopharmaceutical Production Forecast by Region (2021-2026)
Table 102. Global Radiopharmaceutical Sales Volume Forecast by Type (2021-2026)
Table 103. Global Radiopharmaceutical Sales Volume Market Share Forecast by Type (2021-2026)
Table 104. Global Radiopharmaceutical Sales Revenue Forecast by Type (2021-2026)
Table 105. Global Radiopharmaceutical Sales Revenue Market Share Forecast by Type (2021-2026)
Table 106. Global Radiopharmaceutical Sales Price Forecast by Type (2021-2026)
Table 107. Global Radiopharmaceutical Consumption Volume Forecast by Application (2021-2026)
Table 108. Global Radiopharmaceutical Consumption Value Forecast by Application (2021-2026)
Table 109. North America Radiopharmaceutical Consumption Forecast 2021-2026 by Country
Table 110. East Asia Radiopharmaceutical Consumption Forecast 2021-2026 by Country
Table 111. Europe Radiopharmaceutical Consumption Forecast 2021-2026 by Country
Table 112. South Asia Radiopharmaceutical Consumption Forecast 2021-2026 by Country
Table 113. Southeast Asia Radiopharmaceutical Consumption Forecast 2021-2026 by Country
Table 114. Middle East Radiopharmaceutical Consumption Forecast 2021-2026 by Country
Table 115. Africa Radiopharmaceutical Consumption Forecast 2021-2026 by Country
Table 116. Oceania Radiopharmaceutical Consumption Forecast 2021-2026 by Country
Table 117. South America Radiopharmaceutical Consumption Forecast 2021-2026 by Country
Table 118. Rest of the world Radiopharmaceutical Consumption Forecast 2021-2026 by Country
Table 119. Radiopharmaceutical Distributors List
Table 120. Radiopharmaceutical Customers List
Table 121. Porter's Five Forces Analysis
Table 122. Key Executives Interviewed
Figure 1. North America Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 2. North America Radiopharmaceutical Consumption Market Share by Countries in 2020
Figure 3. United States Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 4. Canada Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 5. Mexico Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 6. East Asia Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 7. East Asia Radiopharmaceutical Consumption Market Share by Countries in 2020
Figure 8. China Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 9. Japan Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 10. South Korea Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 11. Europe Radiopharmaceutical Consumption and Growth Rate
Figure 12. Europe Radiopharmaceutical Consumption Market Share by Region in 2020
Figure 13. Germany Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 14. United Kingdom Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 15. France Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 16. Italy Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 17. Russia Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 18. Spain Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 19. Netherlands Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 20. Switzerland Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 21. Poland Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 22. South Asia Radiopharmaceutical Consumption and Growth Rate
Figure 23. South Asia Radiopharmaceutical Consumption Market Share by Countries in 2020
Figure 24. India Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 25. Pakistan Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 26. Bangladesh Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 27. Southeast Asia Radiopharmaceutical Consumption and Growth Rate
Figure 28. Southeast Asia Radiopharmaceutical Consumption Market Share by Countries in 2020
Figure 29. Indonesia Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 30. Thailand Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 31. Singapore Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 32. Malaysia Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 33. Philippines Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 34. Vietnam Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 35. Myanmar Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 36. Middle East Radiopharmaceutical Consumption and Growth Rate
Figure 37. Middle East Radiopharmaceutical Consumption Market Share by Countries in 2020
Figure 38. Turkey Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 39. Saudi Arabia Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 40. Iran Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 41. United Arab Emirates Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 42. Israel Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 43. Iraq Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 44. Qatar Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 45. Kuwait Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 46. Oman Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 47. Africa Radiopharmaceutical Consumption and Growth Rate
Figure 48. Africa Radiopharmaceutical Consumption Market Share by Countries in 2020
Figure 49. Nigeria Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 50. South Africa Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 51. Egypt Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 52. Algeria Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 53. Morocco Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 54. Oceania Radiopharmaceutical Consumption and Growth Rate
Figure 55. Oceania Radiopharmaceutical Consumption Market Share by Countries in 2020
Figure 56. Australia Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 57. New Zealand Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 58. South America Radiopharmaceutical Consumption and Growth Rate
Figure 59. South America Radiopharmaceutical Consumption Market Share by Countries in 2020
Figure 60. Brazil Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 61. Argentina Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 62. Columbia Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 63. Chile Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 64. Venezuelal Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 65. Peru Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 66. Puerto Rico Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 67. Ecuador Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 68. Rest of the World Radiopharmaceutical Consumption and Growth Rate
Figure 69. Rest of the World Radiopharmaceutical Consumption Market Share by Countries in 2020
Figure 70. Kazakhstan Radiopharmaceutical Consumption and Growth Rate (2015-2020)
Figure 71. Global Radiopharmaceutical Production Capacity Growth Rate Forecast (2021-2026)
Figure 72. Global Radiopharmaceutical Revenue Growth Rate Forecast (2021-2026)
Figure 73. Global Radiopharmaceutical Price and Trend Forecast (2015-2026)
Figure 74. North America Radiopharmaceutical Production Growth Rate Forecast (2021-2026)
Figure 75. North America Radiopharmaceutical Revenue Growth Rate Forecast (2021-2026)
Figure 76. East Asia Radiopharmaceutical Production Growth Rate Forecast (2021-2026)
Figure 77. East Asia Radiopharmaceutical Revenue Growth Rate Forecast (2021-2026)
Figure 78. Europe Radiopharmaceutical Production Growth Rate Forecast (2021-2026)
Figure 79. Europe Radiopharmaceutical Revenue Growth Rate Forecast (2021-2026)
Figure 80. South Asia Radiopharmaceutical Production Growth Rate Forecast (2021-2026)
Figure 81. South Asia Radiopharmaceutical Revenue Growth Rate Forecast (2021-2026)
Figure 82. Southeast Asia Radiopharmaceutical Production Growth Rate Forecast (2021-2026)
Figure 83. Southeast Asia Radiopharmaceutical Revenue Growth Rate Forecast (2021-2026)
Figure 84. Middle East Radiopharmaceutical Production Growth Rate Forecast (2021-2026)
Figure 85. Middle East Radiopharmaceutical Revenue Growth Rate Forecast (2021-2026)
Figure 86. Africa Radiopharmaceutical Production Growth Rate Forecast (2021-2026)
Figure 87. Africa Radiopharmaceutical Revenue Growth Rate Forecast (2021-2026)
Figure 88. Oceania Radiopharmaceutical Production Growth Rate Forecast (2021-2026)
Figure 89. Oceania Radiopharmaceutical Revenue Growth Rate Forecast (2021-2026)
Figure 90. South America Radiopharmaceutical Production Growth Rate Forecast (2021-2026)
Figure 91. South America Radiopharmaceutical Revenue Growth Rate Forecast (2021-2026)
Figure 92. Rest of the World Radiopharmaceutical Production Growth Rate Forecast (2021-2026)
Figure 93. Rest of the World Radiopharmaceutical Revenue Growth Rate Forecast (2021-2026)
Figure 94. North America Radiopharmaceutical Consumption Forecast 2021-2026
Figure 95. East Asia Radiopharmaceutical Consumption Forecast 2021-2026
Figure 96. Europe Radiopharmaceutical Consumption Forecast 2021-2026
Figure 97. South Asia Radiopharmaceutical Consumption Forecast 2021-2026
Figure 98. Southeast Asia Radiopharmaceutical Consumption Forecast 2021-2026
Figure 99. Middle East Radiopharmaceutical Consumption Forecast 2021-2026
Figure 100. Africa Radiopharmaceutical Consumption Forecast 2021-2026
Figure 101. Oceania Radiopharmaceutical Consumption Forecast 2021-2026
Figure 102. South America Radiopharmaceutical Consumption Forecast 2021-2026
Figure 103. Rest of the world Radiopharmaceutical Consumption Forecast 2021-2026
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
